Literature DB >> 34310166

Intravenous Iron Therapy in Heart Failure With Reduced Ejection Fraction: Tackling the Deficiency.

Konrad Teodor Sawicki1,2, Hossein Ardehali1,2.   

Abstract

Entities:  

Keywords:  cardiomyopathies; cardiotoxicity; heart failure; iron; metabolism

Mesh：

Substances：

Year:  2021        PMID： 34310166      PMCID： PMC8323966          DOI： 10.1161/CIRCULATIONAHA.121.054271

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   39.918


× No keyword cloud information.
  5 in total

1.  Ferric saccharate induces oxygen radical stress and endothelial dysfunction in vivo.

Authors:  T M Rooyakkers; E S G Stroes; M P Kooistra; E E van Faassen; R C Hider; T J Rabelink; J J M Marx
Journal:  Eur J Clin Invest       Date:  2002-03       Impact factor: 4.686

2.  Oral sucrosomial iron improves exercise capacity and quality of life in heart failure with reduced ejection fraction and iron deficiency: a non-randomized, open-label, proof-of-concept study.

Authors:  Apostolos Karavidas; Efstratios Troganis; George Lazaros; Despina Balta; Ioannis-Nektarios Karavidas; Eftihia Polyzogopoulou; John Parissis; Dimitrios Farmakis
Journal:  Eur J Heart Fail       Date:  2021-01-22       Impact factor: 15.534

3.  IRON-HF study: a randomized trial to assess the effects of iron in heart failure patients with anemia.

Authors:  Luís Beck-da-Silva; Diogo Piardi; Stephan Soder; Luís Eduardo Rohde; Antônio Carlos Pereira-Barretto; Denílson de Albuquerque; Edimar Bocchi; Fábio Vilas-Boas; Lídia Zytynzki Moura; Marcelo W Montera; Salvador Rassi; Nadine Clausell
Journal:  Int J Cardiol       Date:  2013-05-13       Impact factor: 4.164

4.  Iron sucrose accelerates early atherogenesis by increasing superoxide production and upregulating adhesion molecules in CKD.

Authors:  Ko-Lin Kuo; Szu-Chun Hung; Tzong-Shyuan Lee; Der-Cherng Tarng
Journal:  J Am Soc Nephrol       Date:  2014-04-10       Impact factor: 10.121

5.  Reduction in mitochondrial iron alleviates cardiac damage during injury.

Authors:  Hsiang-Chun Chang; Rongxue Wu; Meng Shang; Tatsuya Sato; Chunlei Chen; Jason S Shapiro; Ting Liu; Anita Thakur; Konrad T Sawicki; Sathyamangla V N Prasad; Hossein Ardehali
Journal:  EMBO Mol Med       Date:  2016-03-01       Impact factor: 12.137
  5 in total
  3 in total

1.  Cardiovascular benefits of SGLT2 inhibitors in type 2 diabetes, interaction with metformin and role of erythrocytosis: a self-controlled case series study.

Authors:  Carlos King Ho Wong; Kristy Tsz Kwan Lau; Eric Ho Man Tang; Chi Ho Lee; Carmen Yu Yan Lee; Yu Cho Woo; Ivan Chi Ho Au; Kathryn Choon Beng Tan; David Tak Wai Lui
Journal:  Cardiovasc Diabetol       Date:  2022-06-03       Impact factor: 8.949

2.  Iron homeostasis in heart transplant recipients randomized to ferric derisomaltose or placebo.

Authors:  Kristine V Brautaset Englund; Charlotte M Østby; Kaspar Broch; Thor Ueland; Pål Aukrust; Einar Gude; Arne K Andreassen; Lars Gullestad
Journal:  Clin Transplant       Date:  2022-06-01       Impact factor: 3.456

3.  Iron Deficiency in Heart Failure and Effect of Dapagliflozin: Findings From DAPA-HF.

Authors:  Kieran F Docherty; Paul Welsh; Subodh Verma; Rudolf A De Boer; Eileen O'Meara; Olof Bengtsson; Lars Køber; Mikhail N Kosiborod; Ann Hammarstedt; Anna Maria Langkilde; Daniel Lindholm; Dustin J Little; Mikaela Sjöstrand; Felipe A Martinez; Piotr Ponikowski; Marc S Sabatine; David A Morrow; Morten Schou; Scott D Solomon; Naveed Sattar; Pardeep S Jhund; John J V McMurray
Journal:  Circulation       Date:  2022-08-16       Impact factor: 39.918
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.